BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9596188)

  • 1. Audiologic presentation of vestibular schwannomas in neurofibromatosis type 2.
    Lalwani AK; Abaza MM; Makariou EV; Armstrong M
    Am J Otol; 1998 May; 19(3):352-7. PubMed ID: 9596188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hearing preservation in neurofibromatosis type 2.
    Slattery WH; Brackmann DE; Hitselberger W
    Am J Otol; 1998 Sep; 19(5):638-43. PubMed ID: 9752973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are stage IV vestibular schwannomas preoperatively different from other stages?
    Tringali S; Dubreuil C; Zaouche S; Ferber-Viart C
    Otol Neurotol; 2008 Jan; 29(1):46-9. PubMed ID: 18046259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical acumen and vestibular schwannoma.
    Moffat DA; Baguley DM; Beynon GJ; Da Cruz M
    Am J Otol; 1998 Jan; 19(1):82-7. PubMed ID: 9455955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic neuromas presenting with normal or symmetrical hearing: factors associated with diagnosis and outcome.
    Lustig LR; Rifkin S; Jackler RK; Pitts LH
    Am J Otol; 1998 Mar; 19(2):212-8. PubMed ID: 9520059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralabyrinthine schwannomas.
    Fitzgerald DC; Grundfast KM; Hecht DA; Mark AS
    Am J Otol; 1999 May; 20(3):381-5. PubMed ID: 10337982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intra-labyrinthine schwannomas: a report of two cases].
    Boutin P; Guth A; Bouccara D; el Garem H; Rey A; Sterkers O
    Ann Otolaryngol Chir Cervicofac; 1998 Feb; 115(1):35-41. PubMed ID: 9765709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
    Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
    Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vestibular schwannoma volume as a predictor of hearing outcome after surgery.
    Gjuric M; Mitrecic MZ; Greess H; Berg M
    Otol Neurotol; 2007 Sep; 28(6):822-7. PubMed ID: 17554228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear implantation in neurofibromatosis type 2 after radiation therapy.
    Trotter MI; Briggs RJ
    Otol Neurotol; 2010 Feb; 31(2):216-9. PubMed ID: 19887974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic image (252). A woman with complaints of tinnitus, hearing loss and headache].
    te Lintelo MP; Koehler PJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2565. PubMed ID: 16320667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor growth and audiometric change in vestibular schwannomas managed conservatively.
    Massick DD; Welling DB; Dodson EE; Scholfield M; Nagaraja HN; Schmalbrock P; Chakeres DW
    Laryngoscope; 2000 Nov; 110(11):1843-9. PubMed ID: 11081597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.
    Plotkin SR; Singh MA; O'Donnell CC; Harris GJ; McClatchey AI; Halpin C
    Nat Clin Pract Oncol; 2008 Aug; 5(8):487-91. PubMed ID: 18560388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
    Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
    Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic markers of hearing loss in intralabyrinthine schwannomas: implications for management.
    Santos F; Linthicum FH; House JW; Wilkinson EP
    Otol Neurotol; 2011 Dec; 32(9):1542-7. PubMed ID: 22072265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipsilateral and contralateral acoustic brainstem response abnormalities in patients with vestibular schwannoma.
    Shih C; Tseng FY; Yeh TH; Hsu CJ; Chen YS
    Otolaryngol Head Neck Surg; 2009 Dec; 141(6):695-700. PubMed ID: 19932840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory brainstem implantation in patients with neurofibromatosis type 2.
    Kanowitz SJ; Shapiro WH; Golfinos JG; Cohen NL; Roland JT
    Laryngoscope; 2004 Dec; 114(12):2135-46. PubMed ID: 15564834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochlear origin of early hearing loss in vestibular schwannoma.
    Gouveris HT; Victor A; Mann WJ
    Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.